Skip to main content

Table 2 Distribution of HPV 16 E6 variants for diagnostic category

From: Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern Mexico

Variant

Non-IL N=97

LSIL N=123

HSIL N=19

SCC N=76

ADC N=13

Other Epithelial Tumor N=2

Cervical carcinoma N=91

Total N=330

E variants

87 (89.69%)

108 (87.79%)

15 (78.94%)

53 (69.75%)

7 (53.84%)

1 (50.0%)

61 (67.05%)

271 (82.12%)

Class E-T350

23 (23.72%)

23 (18.7%)

1 (5.26%)

4 (5.26%)

-

-

4 (4.4%)

51 (15.45%)

E-Prototype

17 (17.53%)

23 (18.7%)

1 (5.26%)

2 (2.63%)

-

-

2 (2.2%)

43 (13.03%)

E-G131

6 (6.19%)

-

-

2 (2.63%)

-

-

2 (2.2%)

8 (2.42%)

Class E-G350

64 (65.97%)

85 (69.09%)

14 (73.68%)

49 (64.49%)

7 (53.84%)

1 (50.0%)

57 (62.65%)

220 (66.67%)

E-G350

39 (40.21%)

56 (45.53%)

6 (31.58%)

28 (36. 84%)

3 (23.08%)

-

31 (34.07%)

132 (40.00%)

E-C109/G350

-

3 (2.44%)

1 (5.26%)

2 (2.63%)

-

-

2 (2.2%)

6 (1.82%)

E-G110/G350

1 (1.03%)

1 (0.81%)

-

-

-

-

-

2 (0.61%)

E-G131/G350

1 (1.03%)

-

-

1 (1.32%)

-

-

1 (1.1%)

2 (0.61%)

E-G131/C188/G350

1 (1.03%)

1 (0.81%)

-

-

-

-

-

2 (0.61%)

E-A176/G350

3 (3.09%)

5 (4.07%)

1 (5.26%)

5 (6.58%)

2 (15.38%)

1 (50.0%)

8 (8.79%)

17 (5.15%)

**E-A176/G424/G350

-

-

-

1 (1.32%)

-

-

1 (1.1%)

1 (0.30%)

E-T182/G350

-

1 (0.81%)

1 (5.26%)

2 (2.63%)

-

-

2 (2.2%)

4 (1.21%)

E-C182/G350

1 (1.03%)

1 (0.81%)

-

-

-

-

-

2 (0.61%)

**E-C183/G350

3 (3.09%)

-

-

-

-

-

-

3 (0.91%)

E-G185/G350

1 (1.03%)

-

-

1 (1.32%)

-

-

1 (1.1%)

2 (0.61%)

E-A188/G350

-

-

-

1 (1.32%)

-

-

1 (1.1%)

1 (0.30%)

E-C188/G350

11 (11.34%)

13 (10.57%)

5 (26.32%)

8 (10.53%)

2 (15.38%)

-

10 (10.99%)

39 (11.82%)

**E-C188/G310/G350

1 (1.03%)

1 (0.81%)

-

-

-

-

-

2 (0.61%)

**E-G189/T256/G350

-

1 (0.81%)

-

-

-

-

-

1 (0.30%)

E-G257/G350

-

1 (0.81%)

-

-

-

-

-

1 (0.30%)

**E-C306/G350

1 (1.03%)

-

-

-

-

-

-

1 (0.30%)

E-C442/G350

1 (1.03%)

-

-

-

-

-

-

1 (0.30%)

**G535/G350

-

1 (0.81%)

-

-

-

-

-

1 (0.30%)

AA variants

10 (10.31%)

14 (11.38%)

4 (21.05%)

23 (30.27%)

6 (46.15%)

1 (50.0%)

30 (32.97%)

58 (17.58%)

Class AA-a

4 (4.12%)

11 (8.94%)

3 (15.79%)

12 (15.79%)

5 (38.46%)

1 (50.0%)

18 (19.78%)

36 (10.91%)

AA-a

3 (3.09%)

11 (8.94%)

3 (15.79%)

12 (15.79%)

5 (38.46 %)

1 (50.0%)

18 (19.78%)

35 (10.61%)

**AA-a/C188

1 (1.03%)

-

-

-

-

-

-

1 (0.30%)

Class AA-c

6 (6.19%)

3 (2.44%)

1 (5.26%)

11 (14.48%)

1 (7.69%)

-

12 (13.19%)

22 (6.67%)

AA-c

6 (6.19%)

3 (2.44%)

1 (5.26%)

9 (11.84%)

1 (7.69%)

-

10 (10.99%)

20 (6.07%)

**AA-c/G185

-

-

-

1 (1.32%)

-

-

1 (1.1%)

1 (0.30%)

AA-c/C271

-

-

-

1 (1.32%)

-

-

1 (1.1%)

1 (0.30%)

Af variants

-

1 (0.81%)

-

-

-

-

-

1 (0.30%)

Class Af2-a

-

1 (0.81%)

-

-

-

-

-

1 (0.30%)

Af2-a/C109/G403

-

1 (0.81%)

-

-

-

-

-

1 (0.30%)

  1. -,Indicate that the variant was not found.
Back to article page

Virology Journal

ISSN: 1743-422X